Trial to Evaluate the Efficacy on Local Anesthesia and Safety of 2% Lidocaine HCl With Different Epinephrine Concentration in Patients Undergoing Surgical Extraction of Impacted Lower Third Molars
Phase 4
Completed
- Conditions
- Third Molar
- Registration Number
- NCT02696369
- Lead Sponsor
- Huons Co., Ltd.
- Brief Summary
This study is Phase 4 trial which evaluates the safety and efficacy of 2% Lidocaine HCl with different epinephrine concentration in patients undergoing surgical extraction of impacted lower third molars
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 65
Inclusion Criteria
- Age over 19
- Physical grade 1 or 2 by American Society of Anesthesiologists (ASA)
- Mesioangular or horizontal angulation categorized by winter classification
Exclusion Criteria
- Allergy or hypersensitivity about the investigated products
- Any infection or edema during the extraction
- The following patients: clotting disorder, hyperthyroidism, arteriosclerosis, cardiac insufficiency, other cardiovascular disorders
- Pregnancy or breast-feeding
- Any conditions that the investigator considers not to appropriate for this study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Pain visual analogue scale (VAS) Immediately after the extraction To acess the pain immediately after the surgical extraction of impacted lower third molars
- Secondary Outcome Measures
Name Time Method Pain VAS 2, 4, 6 hours after administration of the investigational product (IP) Bleeding after extraction measured by the operator Immediately after extraction Local anesthetic duration Immediately after onset of anesthesia Questionnaire of satisfaction level of the operator Immediately after extraction Questionnaire of satisfaction level of the subjects Immediately after extraction Dosage of administrated IP immediately after injection Onset time of anesthesia Immediately after administration of IP Onset time of pain after administration of IP Immediately after injection
Trial Locations
- Locations (1)
Huons
🇰🇷Ansan, Kyeonggi-do, Korea, Republic of